Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Sell
93,472
-6,595
-7% -$772K 0.84% 27
2026
Q1
$12M Sell
100,067
-688
-0.7% -$79.4K 0.96% 27
2025
Q4
$10.6M Sell
100,755
-1,029
-1% -$96.6K 0.82% 36
2025
Q3
$8.54M Buy
101,784
+142
+0.1% +$11.7K 0.71% 40
2025
Q2
$8.05M Sell
101,642
-911
-0.9% -$72.4K 0.74% 38
2025
Q1
$9.21M Buy
102,553
+2,433
+2% +$227K 0.88% 35
2024
Q4
$9.96M Buy
100,120
+1,553
+2% +$160K 0.93% 33
2024
Q3
$11.2M Buy
98,567
+946
+1% +$112K 1.07% 28
2024
Q2
$12.1M Sell
97,621
-1,689
-2% -$218K 1.27% 20
2024
Q1
$13.1M Buy
99,310
+173
+0.2% +$21.3K 1.48% 15
2023
Q4
$10.8M Buy
99,137
+8,819
+10% +$915K 1.31% 21
2023
Q3
$9.3M Buy
90,318
+9,083
+11% +$979K 1.46% 18
2023
Q2
$9.37M Sell
81,235
-3,664
-4% -$416K 1.47% 16
2023
Q1
$9.03M Sell
84,899
-891
-1% -$96.2K 1.47% 14
2022
Q4
$9.52M Sell
85,790
-2,289
-3% -$234K 1.5% 16
2022
Q3
$7.58M Buy
88,079
+53
+0.1% +$4.73K 1.28% 17
2022
Q2
$8.03M Sell
88,026
-634
-0.7% -$56.2K 1.29% 17
2022
Q1
$7.28M Buy
88,660
+7,262
+9% +$573K 1.03% 28
2021
Q4
$6.24M Buy
81,398
+590
+0.7% +$47K 1.11% 38
2021
Q3
$6.07M Buy
+80,808
New +$6.15M 1.11% 36
2021
Q1
$6.13M Buy
83,295
+2,240
+3% +$165K 1.04% 36
2020
Q4
$6.33M Buy
81,055
+5,185
+7% +$397K 1.14% 31
2020
Q3
$6M Buy
75,870
+1,034
+1% +$81K 1.15% 26
2020
Q2
$5.52M Buy
74,836
+4,767
+7% +$359K 1.16% 26
2020
Q1
$5.14M Buy
70,069
+5,496
+9% +$432K 1.19% 23
2019
Q4
$5.6M Buy
64,573
+4,730
+8% +$389K 1.03% 26
2019
Q3
$4.81M Sell
59,843
-176
-0.3% -$14.1K 0.98% 30
2019
Q2
$4.8M Buy
60,019
+2,337
+4% +$179K 0.97% 30
2019
Q1
$4.58M Buy
57,682
+687
+1% +$51.4K 0.87% 26
2018
Q4
$4.15M Sell
56,995
-665
-1% -$46.9K 0.92% 29
2018
Q3
$3.9M Sell
57,660
-1,415
-2% -$90.1K 0.8% 31
2018
Q2
$3.42M Buy
59,075
+1,712
+3% +$96.6K 0.74% 32
2018
Q1
$2.98M Buy
57,363
+811
+1% +$43.8K 0.67% 40
2017
Q4
$3.04M Buy
56,552
+1,299
+2% +$72K 0.7% 38
2017
Q3
$3.38M Buy
55,253
+3,470
+7% +$210K 0.8% 31
2017
Q2
$3.17M Buy
51,783
+78
+0.2% +$4.75K 0.8% 30
2017
Q1
$3.13M Buy
51,705
+583
+1% +$35.4K 0.8% 33
2016
Q4
$2.87M Buy
51,122
+6,011
+13% +$352K 0.75% 35
2016
Q3
$2.69M Buy
45,111
+25
+0.1% +$1.46K 0.77% 35
2016
Q2
$2.48M Sell
45,086
-1,521
-3% -$80.9K 0.73% 37
2016
Q1
$2.35M Buy
46,607
+2,117
+5% +$104K 0.74% 36
2015
Q4
$2.24M Buy
44,490
+894
+2% +$45.1K 0.71% 37
2015
Q3
$2.05M Buy
43,596
+654
+2% +$34.7K 0.66% 42
2015
Q2
$2.33M Buy
42,942
+2,383
+6% +$134K 0.63% 38
2015
Q1
$2.22M Buy
40,559
+3,015
+8% +$171K 0.56% 42
2014
Q4
$2.03M Buy
37,544
+8,906
+31% +$496K 0.51% 45
2014
Q3
$1.62M Buy
28,638
+1,811
+7% +$102K 0.42% 48
2014
Q2
$1.48M Buy
26,827
+407
+2% +$22.2K 0.37% 54
2014
Q1
$1.43M Buy
26,420
+1,616
+7% +$83.7K 0.36% 53
2013
Q4
$1.18M Buy
24,804
+3,528
+17% +$161K 0.31% 71
2013
Q3
$966K Buy
21,276
+2,246
+12% +$103K 0.27% 74
2013
Q2
$844K Buy
+19,030
New +$850K 0.26% 74

Other funds holding MRK

Tompkins Financial's MRK Position: Q2 2026 in Review

Tompkins Financial reduced its Merck (MRK) stake by 6.6% in Q2 2026, selling an estimated $772K and leaving 93,472 shares worth $12M. The position accounts for 0.84% of the portfolio, ranked #27.

Tompkins Financial first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tompkins Financial held 93,472 shares of Merck worth $12M as of Q2 2026.
  • Tompkins Financial sold 6,595 Merck shares in Q2 2026, an estimated $772K.
  • Merck made up 0.84% of Tompkins Financial's portfolio in Q2 2026, its #27 holding.
  • Tompkins Financial first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Tompkins Financial's Merck position peaked at $13.1M in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.